An examination of proactive preparedness and readiness review for future enrollment in the agency’s QMM program—now in the pilot stage as an effort to incentivize pharma manufacturers to achieve a more mature state of quality culture.
Sarah Akers
Advertisement
Consultant, Shabas Solutions LLC
Articles by Sarah Akers
Advertisement
Latest Updated Articles
Going Beyond Compliance: Early Adoption of FDA’s Quality Management Maturity Program—and the Practical Considerations for ExecutivesPublished: August 18th 2025 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Continued Coverage of the 2026 J.P. Morgan Healthcare Conference
2
JP Morgan 2026: Novavax Shifting Towards Partnership-Driven Strategy
3
JP Morgan 2026: AbbVie Advances its Pipeline
4
President Trump Asks Congress to Enact 'The Great Healthcare Plan:' Report
5